Clinical Trials · NCT00994929
Efficacy and Safety of IL-11 in DDAVP Unresponsive
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Pittsburgh
- Enrollment
- 9
- Start date
- Jan 2010
- Locations
- 1 site, United States
- Primary endpoint
- Biologic Effects by Coagulation Tests